All 66 XPH (STATE STREET(R) SPDR(R) S&P(R) PHARMACEUTICALS ETF) Holdings
There are 66 XPH holdings. Top 10 companies weight: 24.19%.
Total Market Cap: $2.39T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (66 stocks) | +16.79% | 26.72 | 22.25 | 0.30 | +9.65% | +21.95% | 0.56 | ||||||||||
51 | ARVN | Arvinas Inc | 1.23% | $8.26 | $534M | Biotechnology | Healthcare | +1.07% | N/A | 17.86 | N/A | N/A | N/A | N/A | N/A | N/A | -37.19% | N/A |
52 | AMPH | Amphastar Pharmaceuticals Inc | 1.20% | $19.59 | $866M | Drug Manufacturers - Specialty & Generic | Healthcare | +101.37% | 11.27 | N/A | 2.77 | N/A | N/A | 42 | +12.30% | $22 | -0.82% | 0.70 |
53 | ZVRA | Zevra Therapeutics Inc | 1.11% | $12.45 | $766M | Biotechnology | Healthcare | N/A | 5.89 | 11.93 | 10.67 | N/A | N/A | 80 | +124.02% | $28 | +2.53% | 0.65 |
54 | PHAT | N/A | 1.08% | $11.25 | $878M | Biotechnology | Healthcare | -24.73% | N/A | N/A | N/A | N/A | N/A | 77 | +110.67% | $24 | -19.21% | 1.26 |
55 | CRMD | Cormedix Inc | 1.07% | $8.19 | $660M | Biotechnology | Healthcare | N/A | 3.63 | 16.50 | N/A | N/A | N/A | 90 | +83.15% | $15 | +4.99% | 0.84 |
56 | SEPN | Septerna Inc | 1.00% | $33.68 | $1.53B | Biotechnology | Healthcare | N/A | N/A | 107.53 | N/A | N/A | N/A | 77 | +33.61% | $45 | 0.00% | 1.24 |
57 | TBPH | Theravance Biopharma Inc | 0.95% | $16.84 | $872M | Biotechnology | Healthcare | N/A | 12.26 | 7.91 | N/A | N/A | N/A | 55 | +4.93% | $18 | +4.12% | 0.53 |
58 | ACRS | Aclaris Therapeutics Inc | 0.94% | $5.69 | $782M | Biotechnology | Healthcare | -15.62% | N/A | N/A | N/A | N/A | N/A | 75 | +75.75% | $10 | -18.28% | 0.86 |
59 | RLMD | Relmada Therapeutics Inc | 0.94% | $5.30 | $651M | Biotechnology | Healthcare | -0.59% | N/A | N/A | N/A | N/A | N/A | 80 | +139.06% | $13 | -27.40% | 0.90 |
60 | LBRX | Lb Pharmaceuticals Inc | 0.78% | $32.31 | $922M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +39.28% | $45 | 0.00% | 0.60 |
61 | AQST | Aquestive Therapeutics Inc | 0.72% | $4.04 | $491M | Drug Manufacturers - Specialty & Generic | Healthcare | -17.65% | N/A | N/A | N/A | N/A | N/A | 80 | +120.05% | $8.89 | +1.45% | 1.37 |
62 | FULC | Fulcrum Therapeutics Inc | 0.67% | $3.68 | $237M | Biotechnology | Healthcare | -12.14% | N/A | N/A | N/A | N/A | N/A | 31 | +58.42% | $5.83 | -15.30% | 1.19 |
63 | LXRX | Lexicon Pharmaceuticals Inc | 0.57% | $2.38 | $937M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +58.40% | $3.77 | -7.69% | 1.08 |
64 | EOLS | Evolus Inc | 0.45% | $5.81 | $392M | Drug Manufacturers - Specialty & Generic | Healthcare | -30.42% | N/A | 50.51 | N/A | N/A | N/A | 75 | +152.71% | $15 | -12.27% | 1.17 |
65 | n/a | Ssi Us Gov Money Market Class State Street Inst Us Gov | 0.09% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
66 | n/a | Contra Esperion Therap Common Stock | 0.01% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
XPH (STATE STREET(R) SPDR(R) S&P(R) PHARMACEUTICALS ETF) Sector Allocation
HEALTHCARE
98.30%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%